E. Stockfleth

Merkel Cell Carcinoma: An Update and Review
20234 citationsauthor #1
Severity of Local Skin Reactions with 4% 5-Fluorouracil Plus Emollient versus 4% 5-Fluorouracil Alone in Patients with Actinic Keratosis: A Single-Blind Randomised Trial
20238 citationsauthor #1
German S3 guideline “actinic keratosis and cutaneous squamous cell carcinoma” – long version of the update 2023
20233 citationsauthor #40
Basal Proliferation and Acantholysis May Represent Histological High-Risk Factors for Progression into Invasive Squamous Cell Carcinoma: A Comparison Study in Solid Organ Transplant Recipients and Matched Immunocompetent Patients
20237 citationsauthor #4
An In Vitro Pilot Study Investigating the Antineoplastic Effects of GP-2250 on Cutaneous Squamous Cell Carcinoma Cell Lines: Preliminary Results
20231 citationsauthor #8
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023.
2023188 citationsauthor #27
Multi‐omics approach to understand the impact of sun exposure on an in vitro skin ecosystem and evaluate a new broad‐spectrum sunscreen
20234 citationsauthor #12
Einflussfaktoren auf oberflächliche und tiefe Beinvenenthrombosen nach Schaumverödung von Krampfadern
20223 citationsauthor #3
Encouraging sun protection early in life: from a successful prevention programme in children to the identification of psychological barriers in adolescents
202211 citationsauthor #1
Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action
202231 citationsauthor #2
The Role of Hormones in Hidradenitis Suppurativa: A Systematic Review
202248 citationsauthor #6
Inhibition of Cell Proliferation and Cell Viability by Sinecatechins in Cutaneous SCC Cells Is Related to an Imbalance of ROS and Loss of Mitochondrial Membrane Potential
20225 citationsauthor #6
Epidemiology of Merkel Cell Polyomavirus Infection and Merkel Cell Carcinoma
202232 citationsauthor #5
Protein expression of prognostic genes in primary melanoma and benign nevi
20216 citationsauthor #5
Aggressive cutaneous squamous cell carcinoma in a hydroxyurea‐ and ruxolitinib‐pretreated patient with polycythaemia vera
20219 citationsauthor #2
Expression of Hedgehog signalling molecules in microcystic adnexal carcinoma
20214 citationsauthor #4
High ROS Production by Celecoxib and Enhanced Sensitivity for Death Ligand-Induced Apoptosis in Cutaneous SCC Cell Lines
202114 citationsauthor #4
Volume increase of spleen in melanoma patients undergoing immune checkpoint blockade.
20219 citationsauthor #4
The Role of Circular RNAs in Keratinocyte Carcinomas
20214 citationsauthor #4
Expression of Mismatch Repair Proteins in Merkel Cell Carcinoma
202115 citationsauthor #12
Light and Skin.
202116 citationsauthor #2
The Overall Number of Actinic Keratosis Lesions Is Not Predictable by the Number of Visible Lesions: Consequences for Field-Directed Therapies
20218 citationsauthor #1
Intensity of Local Skin Reactions During 5-Fluorouracil Treatment Related to the Number of Actinic Keratosis Lesions: A Post Hoc, Exploratory Analysis
202117 citationsauthor #1
Actinic keratosis: where do we stand and where is the future going to take us?
202031 citationsauthor #2
Comparative efficacy of cemiplimab versus other systemic treatments for advanced cutaneous squamous cell carcinoma.
202045 citationsauthor #17
Altered hydroxymethylation in cutaneous squamous cell carcinoma and keratoacanthoma
20201 citationsauthor #4
Prognostic significance of an 11-gene RNA assay in archival tissue of cutaneous melanoma stage I-III patients.
202013 citationsauthor #5
Expression of Programmed Cell Death Proteins in Kaposi Sarcoma and Cutaneous Angiosarcoma
202020 citationsauthor #6
Autoimmune radiculoplexus neuropathy under adjuvant nivolumab treatment of a female patient with melanoma
20202 citationsauthor #6
Patched 1 expression in Merkel cell carcinoma
202010 citationsauthor #11
Increased expression profile of NCSTN, Notch and PI3K/AKT3 in hidradenitis suppurativa
202030 citationsauthor #7
S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) – short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow‐up, prevention and occupational disease
202070 citationsauthor #29
Human Papilloma Virus Infections
202011 citationsauthor #2
Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial
202015 citationsauthor #3
Does very early timing of lymph node surgery after resection of the primary tumour improve the clinical outcome of patients with melanoma?
20205 citationsauthor #6
Malignant Epithelial Tumors
20200 citationsauthor #1
S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma – short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality‐of‐care indicators
202092 citationsauthor #29
Dicer Sequencing, Whole Genome Methylation Profiling, mRNA and smallRNA Sequencing Analysis in Basal Cell Carcinoma.
201914 citationsauthor #7
Treatment responder analysis in actinic keratosis: can it lead the way to individualized choice of treatment?
20190 citationsauthor #5
Low Drosha protein expression in cutaneous T‐cell lymphoma is associated with worse disease outcome
20198 citationsauthor #6
Expression of indolamine‐2,3‐dioxygenase and cyclooxygenase‐2 in different disease stages of cutaneous squamous cell carcinoma
20191 citationsauthor #5
Evaluation of two histological classifications for actinic keratoses – PRO classification scored highest inter‐rater reliability
201922 citationsauthor #9
The actinic dysplasia syndrome – diagnostic approaches defining a new concept in field carcinogenesis with multiple cSCC
201921 citationsauthor #5
A Brief Communication on Circulating PD-1-positive T-Regulatory Lymphocytes in Melanoma Patients Undergoing Adjuvant Immunotherapy With Nivolumab
201913 citationsauthor #5
Decreased 5‐hydroxymethylcytosine immunoreactivity in primary Merkel cell carcinoma is a strong predictor for disease‐specific death
20197 citationsauthor #5
Baseline laboratory parameters predicting clinical outcome in melanoma patients treated with ipilimumab: a single‐centre analysis
201821 citationsauthor #5
Response to ‘Phase IV head‐to‐head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp’: reply from the authors
20181 citationsauthor #1
Absence of immunoglobulin heavy chain rearrangement in primary Merkel cell carcinomas
20180 citationsauthor #4
Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis
201812 citationsauthor #1
Topical resiquimod dosing regimens in patients with multiple actinic keratoses: a multicentre, partly placebo‐controlled, double‐blind clinical trial
201814 citationsauthor #1
Nonmelanoma skin cancer – from actinic keratosis to cutaneous squamous cell carcinoma
201827 citationsauthor #3
IV阶段一对一随机对照试验就治疗面部或头皮光化性角化病比较了巨大戟醇甲基丁烯酸酯0.015%凝胶与双氯芬酸钠3%凝胶
20180 citationsauthor #1
Actinic keratoses seldom occur alone
20180 citationsauthor #2
Argon plasma coagulation of actinic keratoses imaged by optical coherence tomography: An in vivo study indicating a possible lesion‐directed treatment
20182 citationsauthor #7
Dermatology today and tomorrow: from symptom control to targeted therapy
201830 citationsauthor #5
Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy
20183 citationsauthor #2
CHLAMYDIA INFECTION
201843 citationsauthor #119
Histological intralesional heterogeneity of actinic keratoses relates to field cancerization
20186 citationsauthor #4
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
201812 citationsauthor #2
Actinic keratoses show variable histological basal growth patterns – a proposed classification adjustment
201868 citationsauthor #6
Diclofenac Sodium 3% in Hyaluronic Acid 2.5% Gel Significantly Diminishes the Actinic Keratosis Area and Severity Index
20186 citationsauthor #7
Phase IV head‐to‐head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp
20181 citationsauthor #1
Altered Global 5-Hydroxymethylation Status in Hidradenitis Suppurativa: Support for an Epigenetic Background
201713 citationsauthor #9
Supplementary Material for: Altered Global 5-Hydroxymethylation Status in Hidradenitis Suppurativa: Support for an Epigenetic Background
20170 citationsauthor #9
Efficacy and Safety of Three Cryotherapy Devices for Wart Treatment: A Randomized, Controlled, Investigator-Blinded, Comparative Study
201724 citationsauthor #5
Erratum to: Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial
20172 citationsauthor #1
Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort study
201773 citationsauthor #43
Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology
201799 citationsauthor #4
536 Sonidegib duration of response across 30 months: Results from the randomized phase 2 BOLT trial
20170 citationsauthor #1
Expression of PD-L1 in keratoacanthoma and different stages of progression in cutaneous squamous cell carcinoma
201730 citationsauthor #4
Expression of PIWIL3 in primary and metastatic melanoma
201717 citationsauthor #7
Expression of oncogenic miR-17-92 and tumor suppressive miR-143-145 clusters in basal cell carcinoma and cutaneous squamous cell carcinoma.
201740 citationsauthor #6
Tumor vascularization and clinicopathologic parameters as prognostic factors in merkel cell carcinoma
201713 citationsauthor #9
Gene-signature based prediction of relapse-free survival in melanoma patients with known sentinel lymph node status.
20175 citationsauthor #10
542 Sonidegib tolerability across 30-months: Results from the phase 2 randomized BOLT trial
20170 citationsauthor #1
Left-sided laterality of Merkel cell carcinoma in a German population: more than just sun exposure
201720 citationsauthor #11
Prognostic relevance of high atonal homolog-1 expression in Merkel cell carcinoma
201623 citationsauthor #11
BH3‐only protein Bim predicts advanced stage of cutaneous melanoma
20163 citationsauthor #4
Biological Effects of Ingenol Mebutate Gel in Moderate to Severe Actinic Fields Assessed by Reflectance Confocal Microscopy: A Phase I Study.
201613 citationsauthor #8
Adherence to topical therapies in actinic keratosis: A literature review
201624 citationsauthor #2
Stress-coping styles of 459 emergency care physicians in Germany
201611 citationsauthor #7
Circular RNA expression in basal cell carcinoma.
201687 citationsauthor #7
Cost of Treatment of Actinic Keratosis on the Face/Scalp in Sweden
20162 citationsauthor #1
Circular RNA expression in cutaneous squamous cell carcinoma.
2016124 citationsauthor #7
Expression profiles of long noncoding RNAs in cutaneous squamous cell carcinoma.
201630 citationsauthor #7
Patient-reported Outcomes: Association with Clinical Response to Psoriasis Therapies
20160 citationsauthor #10
Efficacy and Safety of Imiquimod 3.75% from Lmax in Actinic Keratosis According to Fitzpatrick Skin Type.
20165 citationsauthor #2
Decreased expression of ten‐eleven translocation 2 protein is associated with progressive disease and death in patients with mycosis fungoides
20166 citationsauthor #7
A pilot study of quality of life in German prehospital emergency care physicians
20167 citationsauthor #7
Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial
201633 citationsauthor #1
New Topical Treatment Options for Actinic Keratosis: A Systematic Review.
201623 citationsauthor #1
Prognostic value of the area and density of lymphatic vessels in cutaneous squamous cell carcinoma
201611 citationsauthor #7
Mutation Scanning of D1705 and D1709 in the RNAse IIIb Domain of MicroRNA Processing Enzyme Dicer in Cutaneous Melanoma
20163 citationsauthor #7
Actinic keratosis: correlation between clinical and histological classification systems
2016115 citationsauthor #5
Field Treatment of Actinic Keratosis With Ingenol Mebutate.
20164 citationsauthor #2
Long-noncoding RNAs in basal cell carcinoma
201634 citationsauthor #7
Occupational syncarcinogenesis in the skin – combined effects of two carcinogens from the German occupational disease list
20169 citationsauthor #5
Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by.
20161 citationsauthor #10
Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma
201578 citationsauthor #7
Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma
201578 citationsauthor #6

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT